Analysts Anticipate Olin Co. (NYSE:OLN) to Post $0.06 Earnings Per Share
Brokerages expect Olin Co. (NYSE:OLN) to announce $0.06 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Olin’s earnings. The lowest EPS estimate is ($0.06) and the highest is $0.26. Olin reported earnings per share of $0.54 in the same quarter last year, which would suggest a negative year-over-year growth rate of 88.9%. The company is expected to issue its next earnings report after the market closes on Wednesday, July 31st.
On average, analysts expect that Olin will report full-year earnings of $1.41 per share for the current year, with EPS estimates ranging from $0.90 to $1.76. For the next fiscal year, analysts anticipate that the business will report earnings of $2.22 per share, with EPS estimates ranging from $1.83 to $2.68. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side analysts that follow Olin.
Olin (NYSE:OLN) last posted its earnings results on Tuesday, April 30th. The specialty chemicals company reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.04). The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.69 billion. Olin had a return on equity of 11.12% and a net margin of 5.14%. The business’s quarterly revenue was down 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.12 EPS.
In related news, EVP John L. Mcintosh sold 10,500 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $21.74, for a total transaction of $228,270.00. Following the transaction, the executive vice president now directly owns 100,812 shares of the company’s stock, valued at $2,191,652.88. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP John L. Mcintosh sold 19,335 shares of the firm’s stock in a transaction dated Wednesday, May 22nd. The stock was sold at an average price of $22.54, for a total transaction of $435,810.90. Following the transaction, the executive vice president now directly owns 81,477 shares in the company, valued at $1,836,491.58. The disclosure for this sale can be found here. 1.90% of the stock is currently owned by company insiders.
Large investors have recently added to or reduced their stakes in the stock. Thrivent Financial for Lutherans increased its position in Olin by 5.2% during the fourth quarter. Thrivent Financial for Lutherans now owns 42,430 shares of the specialty chemicals company’s stock worth $853,000 after acquiring an additional 2,090 shares during the period. Deprince Race & Zollo Inc. bought a new position in Olin during the fourth quarter worth about $20,040,000. Mackay Shields LLC increased its position in Olin by 981.8% during the fourth quarter. Mackay Shields LLC now owns 98,881 shares of the specialty chemicals company’s stock worth $1,989,000 after acquiring an additional 89,741 shares during the period. New York State Teachers Retirement System increased its position in Olin by 8.0% during the first quarter. New York State Teachers Retirement System now owns 151,781 shares of the specialty chemicals company’s stock worth $3,512,000 after acquiring an additional 11,300 shares during the period. Finally, Royce & Associates LP increased its holdings in Olin by 30.1% in the 1st quarter. Royce & Associates LP now owns 302,916 shares of the specialty chemicals company’s stock valued at $7,009,000 after buying an additional 70,000 shares during the period. 91.79% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE OLN traded down $0.27 during mid-day trading on Tuesday, reaching $21.15. 1,752,224 shares of the company were exchanged, compared to its average volume of 1,854,928. The firm’s 50-day moving average is $21.51. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.48 and a quick ratio of 0.85. The company has a market capitalization of $3.49 billion, a PE ratio of 12.09, a P/E/G ratio of 0.72 and a beta of 1.54. Olin has a twelve month low of $17.87 and a twelve month high of $32.00.
Olin Corporation manufactures and distributes chemical products in the United States and internationally. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, chlorinated organics intermediates and solvents, and sodium hypochlorite.The Epoxy segment provides allyl chloride and epichlorohydrin, as well as acetone, bisphenol, cumene, and phenol for use in resins and other plastic materials, water purification, and pesticides, as well as for the manufacturers of polymers; liquid and solid epoxy resins that are used in adhesives, paints and coatings, composites, and flooring; and differentiated epoxy resins for use in electrical laminates, paints and coatings, wind blades, electronics, and construction, as well as offers additives.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.